ArticleInternational journal of general medicine2026
Predictive Value of Combined Serum NOX4, Gal-13, and Cyclophilin A for Prognosis in Severe Pneumonia.
Article in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To analyze the predictive value of the combined use of serum NADPH oxidase 4 (NOX4), galectin-13 (Gal-13), and cyclophilin A (CyPA) for poor prognosis in patients with severe pneumonia(SP). Methods: This study was a retrospective study.A total of 172 patients with SP admitted to our hospital from September 2023 to September 2025 were enrolled. They were assigned into the good prognosis group (n=98) and the poor prognosis group (n=74) according to the prognosis at 28 days. The levels of NOX4, Gal-13 and CyPA in the serum of patients were detected by ELISA. The point-biserial method was conducted to analyze correlations. Logistic method was conducted to discuss the influencing factors.Receiver operating characteristic (ROC) curve was used to discuss the predictive efficiency. In addition, decision curve analysis(DCA) was used to analyze their clinical application value. Results: The CPIS score and the levels of serum CRP, PCT, NOX4, Gal-13 and CyPA in the poor prognosis group were higher than those in the good prognosis group ( Conclusion: Detecting the levels of serum NOX4, Gal-13 and CyPA in patients at admission can assist clinicians in evaluating the prognosis of patients with SP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.